Ref (type) | Population | Outcome, Interventions | Results and statistical analysis | Effect size | Favours |
Physical functioning | |||||
RCT |
60 adults with CFS (CDC criteria) attending a secondary-care centre In review |
Predefined increase in functional score (assessed by SF-36 questionnaire)
13 weeks
19/30 (63%) with CBT 5/30 (17%) with relaxation |
RR 3.70 95% CI 2.37 to 6.31 NNT 3 95% CI 1 to 7 |
Moderate effect size | CBT |
RCT 3-armed trial |
153 adults with CFS (CDC criteria) In review |
Change in functional score (assessed by SF-36 questionnaire)
with group CBT with usual care Absolute results not reported |
Absolute difference –1.63 for group CBT v usual care 95% CI –4.05 to +0.78 |
Not significant | |
RCT 3-armed trial |
153 people with CFS (CDC criteria) In review |
Change in functional score (assessed by SF-36 questionnaire)
with group CBT with education and support Absolute results not reported |
Absolute difference –1.23 for group CBT v education and support 95% CI –3.52 to +1.05 |
Not significant | |
RCT 4-armed trial |
90 adults with a mean age of 39.6 years who fulfilled diagnostic criteria for CFS (not further defined) In review |
Mean number of non-sedentary hours
7 months (3 months after completion of treatment)
5.2 with CBT plus placebo 5.2 with usual care plus placebo |
Significance not assessed |
||
RCT 4-armed trial |
90 adults with a mean age of 39.6 years who fulfilled diagnostic criteria for CFS (not further defined) In review |
Mean score for ability to participate in daily activities (Karnofsky performance score)
7 months (3 months after completion of treatment)
72.1 with CBT plus placebo 73.4 with usual care plus placebo |
Significance not assessed |
||
RCT 4-armed trial |
114 adults with CFS (defined by CDC criteria); baseline physical functioning scores 46.36 in people receiving CBT, 53.77 in people receiving relaxation In review |
Mean score on SF-36 for physical functioning
12 months
58.64 with CBT 61.20 with relaxation therapy |
Significance not assessed |
||
RCT |
69 children and adolescents aged 10 to 17 years with CFS (CDC criteria) |
Change in functional score (assessed by short-form [SF]-36 questionnaire)
5 months
27.3 with CBT 10.0 with no treatment |
Absolute difference 17.3 95% CI 6.2 to 28.4 |
Effect size not calculated | CBT |
RCT |
63 adolescents aged 11–18 years with CFS (CDC or Oxford criteria) In review |
Mean score on SF-36 for physical functioning
6 months post treatment
80.4 with family-focused CBT 64.0 with psycho-education |
Adjusted mean difference +13.42 95% CI –2.14 to +29.00 P = 0.09 Mean difference adjusted for associated baseline values |
Not significant | |
RCT |
131 adolescents aged 12–18 years with CFS (CDC criteria) In review |
Physical functioning (assessed by CHQ-CF87)
6 months
88.5 with internet CBT 70.1 with usual care |
Mean difference 18.4 95% CI 12.9 to 23.9 P <0.0001 |
Effect size not calculated | CBT |
RCT 4-armed trial |
641 adults with CFS (Oxford criteria) |
Mean score on SF-36 for physical functioning
52 weeks
58.2 with CBT 50.8 with specialist medical care |
Mean difference 7.1 95% CI 2.0 to 12.1 P = 0.0068 |
Effect size not calculated | CBT |